Administrative Core
Administrative Core
批准号:
10230524
负责人:
Charles G. Mullighan
金额:
$2.56万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-19 至 2024-08-31
关键词:
Acute leukemiaBiological ModelsBiologyBudgetsChemical AgentsChemicalsChildChromatinCitiesCollaborationsCommunitiesComplexCore FacilityDana-Farber Cancer InstituteDataDevelopmentEnsureExperimental ModelsFusion Oncogene ProteinsGenetic TranscriptionGenomicsGoalsGrantHuman ResourcesInternetLesionMemorial Sloan-Kettering Cancer CenterMolecularNUP98 geneOccupational activity of managing financesOutcomePeriodicityPhasePre-Clinical ModelProductivityReagentRecurrent diseaseRegulationReportingResearchResearch ActivityResearch Project GrantsResourcesRoleSaint Jude Children&aposs Research HospitalSiteTelephoneTestingTherapeuticTranslatingTranslationsTreatment EfficacyUnited States National Institutes of Healthbaseconventional therapydata sharinggenome editinghigh riskhuman modelleukemialeukemogenesismeetingsmouse modelnovel therapeutic interventionpre-clinicalpreventresponsesharing platformskillssmall moleculesynergismtargeted treatmentweb site
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY – Administrative Core
Children with NUP98-rearranged acute leukemias demonstrate a poor response to conventional therapy and
are associated a high rate of relapsed disease and poor outcome. These fusions account for approximately
10% of children with AML, yet our overall understanding of the molecular consequences of fusion oncoprotein
expression has been limited in part by a paucity of suitable model systems, which in turn has prevented the
development of rational and targeted therapeutic approaches. The overarching goals of the FusOnC2 Center
for Experimental and Preclinical Modeling of NUP98 Acute Leukemia are to understand the mechanistic basis
of leukemogenesis and develop and translate new, more effective therapeutic approaches for this form of
leukemia. These goals are to be accomplished in four research projects utilizing three core facilities,
Administrative, Genome Editing and Chemical Biology in four academic research centers: St Jude Children’s
Research Hospital, Memorial Sloan Kettering Cancer Center, Dana Farber Cancer Institute, and City of Hope.
The projects will perform experimental modeling of NUP98 and concomitant genomic lesions in mouse and
human models and test activity of chemical agents (Project 1); examine the role of NUP98 fusions on
transcriptional and chromatin complex assembly (Project 2); examine the role of phase separation in
transcriptional deregulation in leukemogenesis (Project 3); and develop and test new small molecule and
degrader therapeutic approaches (Project 4). The Center will be highly interactive and collaborative, with
interactions between projects and cores synergizing to accelerate the pace of discovery and translation for
this high risk form of leukemia. The Administrative Core will be located at St Jude and comprise an Executive
Management Team, administrative, grants and project management assistance. The Administrative Core will
facilitate administrative support for progress meetings, on site and FusOnC2 meetings, financial
management, internal and external data sharing and website, ensure compliance with all institutional, state
and federal regulations, and coordinate periodic reporting of research activity to the NIH.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
-
批准号:10829603
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2023
-
负责人:Charles G. Mullighan
-
依托单位:
Project 1
-
批准号:10900856
-
项目类别:
-
资助金额:$16.15万
-
财政年份:2023
-
负责人:Charles G. Mullighan
-
依托单位:
Childhood Hematological Malignancies Training Program
-
批准号:10456864
-
项目类别:
-
资助金额:$28.95万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Project 1
-
批准号:10230527
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Project 2
-
批准号:10230528
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Project 2
-
批准号:10228887
-
项目类别:
-
资助金额:$2.28万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Childhood Hematological Malignancies Training Program
-
批准号:10226110
-
项目类别:
-
资助金额:$17.41万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
-
批准号:10228882
-
项目类别:
-
资助金额:$15.96万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Genome Core
-
批准号:10228884
-
项目类别:
-
资助金额:$2.28万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Genome Core
-
批准号:10230525
-
项目类别:
-
资助金额:$2.56万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Project 1
-
批准号:10228886
-
项目类别:
-
资助金额:$2.28万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Experimental and preclinical modeling of NUP98-rearranged acute leukemia
-
批准号:10230523
-
项目类别:
-
资助金额:$17.95万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Childhood Hematological Malignancies Training Program
-
批准号:10673699
-
项目类别:
-
资助金额:$27.06万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Administrative Core
-
批准号:10228883
-
项目类别:
-
资助金额:$2.28万
-
财政年份:2019
-
负责人:Charles G. Mullighan
-
依托单位:
Translating genomic discoveries to improved outcomes for high risk acute leukemia
-
批准号:10738122
-
项目类别:
-
资助金额:$109.2万
-
财政年份:2017
-
负责人:Charles G. Mullighan
-
依托单位:
Translating genomic discoveries to improved outcomes for high risk acute leukemia
-
批准号:10318911
-
项目类别:
-
资助金额:$105.55万
-
财政年份:2017
-
负责人:Charles G. Mullighan
-
依托单位:
Translating genomic discoveries to improved outcomes for high risk acute leukemia
-
批准号:10544290
-
项目类别:
-
资助金额:$105.55万
-
财政年份:2017
-
负责人:Charles G. Mullighan
-
依托单位:
Functional analysis of leukemic CREBBP mutations
-
批准号:9063528
-
项目类别:
-
资助金额:$36.31万
-
财政年份:2012
-
负责人:Charles G. Mullighan
-
依托单位:
Functional analysis of leukemic CREBBP mutations
-
批准号:8683126
-
项目类别:
-
资助金额:$35.22万
-
财政年份:2012
-
负责人:Charles G. Mullighan
-
依托单位:
GENOMIC ANALYSIS OF ADOLESCENT AND YOUNG ADULT ACUTE LYMPHOBLASTIC LEUKEMIA
-
批准号:7942948
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:Charles G. Mullighan
-
依托单位:
海外基金